Bcl-2 is a negative regulator of interleukin-1 secretion in murine macrophages in pharmacological-induced apoptosis

British Journal of Pharmacology

Volumn 160, Issue 7, 2010, Pages 1844-1856

  Escandell, J M ^a   Recio, M C ^a   Giner, R M ^a   Manez S ^a   Rios J L ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

apoptosis; Bcl 2; caspase 1; cucurbitacin R; interleukin 1; RAW 264.7 macrophages

Indexed keywords

CASPASE 3; CASPASE 9; CUCURBITACIN; CUCURBITACIN R; DNA; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; LIPOPOLYSACCHARIDE; MESSENGER RNA; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P17; PROTEIN P21; PROTEIN P53; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOWN REGULATION; FLOW CYTOMETRY; GENETIC TRANSFECTION; INFLAMMATION; INHIBITION KINETICS; MACROPHAGE; NEGATIVE FEEDBACK; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOPTOSIS; BLOTTING, WESTERN; CASPASE 1; CASPASE 3; CELL CYCLE; CELL LINE; FLOW CYTOMETRY; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; MACROPHAGES; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; PROTO-ONCOGENE PROTEINS C-BCL-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; TRANSFECTION; TRITERPENES;

EID: 77954317279     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2010.00856.x     Document Type: Article

References (28)

1. Alnemri ES, Livingston DJ, Nicholson DW, Salvesen G, Thornberry NA, Wong WW et al. (1996). Human ICE/CED-3 protease nomenclature. Cell 87:171.
2. Kip1 and cyclin D2 via the PI3-K signalling pathway to mediate cell cycle arrest and apoptosis of WEHI 231 B cells. Oncogene 20:7352 7367.
3. Bleackley RC, Heibein JA (2001). Enzymatic control of apoptosis. Nat Prod Rep 18:431 440.
4. L regulate proinflammatory caspase-1 activation by interaction with NALP1. Cell 129:45 56.
5. Cao Z, Henzel WJ, Gao X (1996a). IRAK: a kinase associated with the interleukin-1 receptor. Science 271:1128 1131.
6. Cao Z, Xiong J, Takeuchi M, Kurama T, Goeddel D (1996b). TRAF6 is a signal transducer for interleukin-1. Nature 383:443 446.
7. Cerretti EP, Kozolsky CJ, Mosley B, Nelson N, Van Ness K, Greenstreet TA et al. (1992). Molecular cloning of the interleukin-1 converting enzyme. Science 256:97 100.
8. Dinarello CA (1998). Interleukin-1, interleukin-18, and the interleukin-1 converting enzyme. Ann N Y Acad Sci 856:1 11.
9. Escandell JM, Recio MC, Máñez S, Giner RM, Cerdá-Nicolás M, Ríos JL (2006). Dihydrocucurbitacin B, isolated from Cayaponia tayuya, reduces damage in adjuvant-induced arthritis. Eur J Pharmacol 532:145 154.
10. Escandell JM, Recio MC, Giner RM, Máñez S, Cerdá-Nicolás M, Ríos JL (2007a). Cucurbitacin R reduces the inflammation and bone damage associated with adjuvant arthritis in Lewis rats by suppression of TNF- in T lymphocytes and macrophages. J Pharmacol Exp Ther 320:581 590.
11. Escandell JM, Recio MC, Máñez S, Giner RM, Cerdá-Nicolás M, Gil-Benso R et al. (2007b). Dihydrocucurbitacin B inhibits delayed-type hypersensitivity reaction by suppressing lymphocyte proliferation. J Pharmacol Exp Ther 322:1261 1268. (Pubitemid 47295806)
12. Escandell JM, Kaler P, Recio MC, Sasazuki T, Shirasawa S, Augenlicht L et al. (2008). Activated kRas protects colon cancer cells from cucurbitacin-induced apoptosis: the role of p53 and p21. Biochem Pharmacol 76:198 207.
13. Gartel AL, Radhakrishnan SK (2005). Lost in transcription: p21 repression, mechanisms, and consequences. Cancer Res 65:3980 3985.
14. Greten FR, Arkan MC, Bollrath J, Hsu LC, Goode J, Miething C et al. (2007). NF-B is a negative regulator of IL-1 secretion as revealed by genetic and pharmacological inhibition of IKK. Cell 130:918 931.
15. Harms KL, Chen X (2005). The C terminus of p53 family proteins is a cell fate determinant. Mol Cell Biol 25:2014 2030.
16. Hogquist KA, Nett MA, Unanue ER, Chaplin DD (1991). Interleukin 1 is processed and released during apoptosis. Proc Natl Acad Sci USA 88:8485 8489.
17. Karin M, Yamamoto Y, Wang QM (2004). The IKK NF-B system: a treasure trove for drug development. Nat Rev Drug Discov 3:17 26.
18. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES et al. (1997). Cytochrome c and dATP-dependent formation of Apaf-1/caspase 9 complex initiates an apoptotic protease cascade. Cell 91:479 489.
19. Martinon F, Tschopp J (2004). Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell 117:561 574.
20. Park JM, Greten FR, Wong A, Westrick RJ, Arthur JSC, Otsu K et al. (2005). Signaling pathways and genes that inhibit pathogen-induced macrophage apoptosis - CREB and NF-B as key regulators. Immunity 23:319 329.
21. Petrilli V, Papin S, Tschopp J (2005). The inflammasome. Curr Biol 15:R581.
22. Recio MC, Prieto M, Bonucelli M, Orsi C, Máñez S, Giner RM et al. (2004). Anti-inflammatory activity of two cucurbitacins isolated from Cayaponia tayuya roots. Planta Med 70:414 420.
23. Ríos JL, Escandell JM, Recio MC (2005). New insight on the bioactivity of cucurbitacins. In:Atta-ur-Rahman (ed.). Studies in Natural Products Chemistry: Bioactive Natural Products, Vol. 32. Elsevier
24. St-Louis MC, Archambault D (2007). The equine arteritis virus induces apoptosis via caspase-8 and mitochondria-dependent caspase-9 activation. Virology 367:147 155.
25. Sun J, Blaskovich MA, Jove R, Livingston SK, Coppola D, Sebti SM (2005). Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity. Oncogene 24:3236 3245.
26. Thornberry NA, Bull HG, Calaycay JR, Chapman KT, Howard AD, Kostura MJ et al. (1992). A novel heterodimeric cysteine protease is required for interleukin-1 processing in monocytes. Nature 356:768 774.
27. Vadiveloo PK, Christopoulos H, Novak U, Kola I, Hertzog PJ, Hamilton JA (2000). Type I interferons mediate the lipopolysaccharide induction of macrophage cyclin D2. J Interferon Cytokine Res 20:355 359.
28. Wu G, Shi Y (2007). Apoptosis signaling pathways and lymphocyte homeostasis. Cell Res 17:759 771.